iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Download App

Dr Reddy's Lab gets EIR for Srikakulam facility from USFDA

26 Aug 2022 , 09:18 AM

Dr Reddy’s Laboratories Limited has further informed to the exchanges on the inspection conducted by the United States Food & Drug Administration (USFDA) at its formulations manufacturing facility (FTO 11) in Srikakulam, Andhra Pradesh.
The company informed that it has received the Establishment Inspection Report (EIR) from USFDA for its Srikakulam facility. 
It further informed that now, the Agency has concluded that the inspection is finally ‘closed’.

At around 9:18 AM, Dr Reddys Laboratories Ltd is currently trading at Rs4,240.45 per share down by Rs0.75 or 0.02% from its previous closing of Rs4,241.20 per share on the BSE.

For feedback and suggestions, write to us at editorial@iifl.com

Related Tags

  • Dr Reddys Laboratories
  • Dr Reddys Laboratories Ltd
  • Dr Reddys Laboratories Ltd approval
  • Dr Reddys Laboratories Ltd EIR
  • Dr Reddys Laboratories Ltd launch
  • Dr Reddys Laboratories Ltd market
  • Dr Reddys Laboratories Ltd news
Download App

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.